Cytokinetics (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cytokinetics" in English language version.

refsWebsite

Global rank English rank

2lifescienceleader.com

low place

2fiercebiotech.com

low place

8,828^th place

1globenewswire.com

2,614^th place

1,549^th place

1web.archive.org

1^st place

1bioworld.com

low place

1yahoo.com

38^th place

40^th place

1nasdaq.com

2,740^th place

2,050^th place

1bizjournals.com

407^th place

241^st place

1endpts.com

low place

1mdmag.com

low place

1cardiovascularbusiness.com

low place

1healio.com

low place

1spglobal.com

4,563^rd place

2,868^th place

1alsnewstoday.com

low place

1ddn-news.com

low place

alsnewstoday.com

MSc, Margarida Azevedo. "Reldesemtiv (Formerly CK-2127107) - ALS News Today". Retrieved 2021-12-02.

bioworld.com

"Myokardia posts positive phase III for mavacamten". www.bioworld.com. Retrieved 2020-07-06.

bizjournals.com

"New CEO at Cytokinetics." San Francisco Business Times. 22 Jan 2007. [1]

cardiovascularbusiness.com

Casey, T. "Oral heart failure medication proves safe, effective in Phase 2 trial." Cardiovascular Business. 5 Dec 2015. [3]

ddn-news.com

"Healthy data for Cytokinetics' HCM candidate". www.ddn-news.com. Retrieved 2020-07-09.

endpts.com

"Cytokinetics nabs Chinese partner, up to $450M as CV becomes company focus". Endpoints News. Retrieved 2020-10-22.

fiercebiotech.com

"Astellas bites off $490M deal to develop muscle drugs with Cytokinetics". FierceBiotech. 25 June 2013. Retrieved 2020-10-28.
"Amgen kicks heart failure med back to Cytokinetics after 'GALACTIC' flop". FierceBiotech. 23 November 2020. Retrieved 2021-04-23.

globenewswire.com

"Cytokinetics Reports Fourth Quarter 2023 Financial Results". Cytokinetics. 29 February 2024. Retrieved 29 February 2024.

healio.com

"Novel myosin activator for HFrEF nets FDA fast track designation". www.healio.com. Retrieved 2020-08-27.

lifescienceleader.com

"Cytokinetics: Keeping Its Sights On Independence". Life Science Leader. Archived from the original on 2020-06-26. Retrieved 2020-06-24.
"Cytokinetics: Keeping Its Sights On Independence". www.lifescienceleader.com. Retrieved 2020-11-19.

mdmag.com

Penberthy, W T. "Omencamtiv Mecarbil Improves Symptoms in Patients with Moderate to Severe Heart Failure." MD Magazine. 18 Sept 2016. [2]

nasdaq.com

"Cytokinetics Inc (CYTK) IPO." Nasdaq. 29 Apr 2004

spglobal.com

"Amgen terminates collaboration with Cytokinetics on 2 experimental heart drugs". www.spglobal.com. Retrieved 2021-04-23.

web.archive.org

"Cytokinetics: Keeping Its Sights On Independence". Life Science Leader. Archived from the original on 2020-06-26. Retrieved 2020-06-24.

yahoo.com

finance.yahoo.com

"3 Biotech Stocks Surging on Positive Results". finance.yahoo.com. Retrieved 2020-07-06.